EPCEdgewell Personal Care Company

$28.06+44% 1Y

Is the price fair?

Watch

A demanding price: at the top of its own P/E range and rich vs its sector.

2 to watch, 1 without data
What the price assumes~+8% a year

Priced for ~8% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangedearest in 29 quartersderived

Expensive vs its own history: P/E 36.8 vs a 19.0 median over 29 quarters (+94% vs median).

Vs sector (EV/EBIT)119.6×

Sector median 17.7× across 76 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What EPC's price assumes

Today's price asks for 8.4% free cash flow growth a year; over the last three years Edgewell Personal Care Company delivered −29%, so the price is ahead of the record.

0.58

Price / sales · no P/E: the last twelve months did not end in a profit

Free cash flow yield
4.0%

Free cash flow yield · Household & Personal Products median 5.1%

Growth the price implies
+8.4%

Growth the price implies · The price pays for +8.4% free cash flow growth a year for a decade; the business has delivered −29% a year over the last three.

Price / book
0.89

Price / book · today's price, trailing year to Jun 30, 2026

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
0.89
EV / EBIToperating margin 0.80%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jun 30, 2026
0.95
Free cash flow, trailing twelve months
$52M
Market capitalisation46.1 million shares, counted Jul 31, 2026
$1.29B
3-year revenue growth
−0.16%
3-year free cash flow growth
−29%

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.

On our screens:Most shorted stocks